On the other hand, evaluating tumor response with [68Ga]Ga-PSMA-11 PET/CT (via the same mechanism of the treatment itself) can also be debated, as potential non-PSMA avid disease will not be evaluated. This evidence concerns the gene FOLH1 and neoplasm.